Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 4, 2009, Pages 1119-1130

  De Castro, Maria ^a   Orive, Gorka ^a   Hernández, Rosa M ^a   Bartkowiak, Artur ^b   Brylak, W ^b   Pedraz, José L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b WEST POMERANIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Alginate; C2C12 cells; Encapsulation; Erythropoietin; Mechanical properties; Oligochitosan

Indexed keywords

ALGINATE MICROCAPSULES; ALGINATE/CA; BALB/C MICE; C2C12 CELLS; CELL MICROENCAPSULATION; CONTROL GROUPS; ENCAPSULATED CELL; HISTOLOGICAL ANALYSIS; IN-VIVO; MECHANICAL EVALUATION; MICROCAPSULES; MYOBLAST CELLS; OLIGOCHITOSAN; POLY-L-LYSINE; STATISTICAL DIFFERENCES;

ALGINATE; AMINO ACIDS; ANIMALS; BIOCOMPATIBILITY; CATALYST ACTIVITY; CELL CULTURE; DIELECTRIC DEVICES; ENCAPSULATION; FLUORINE CONTAINING POLYMERS; MECHANICAL PROPERTIES;

BIOMECHANICS;

CALCIUM ALGINATE; CHITOSAN; ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; CELL ENCAPSULATION; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEMATOCRIT; HISTOLOGY; IMMOBILIZED CELL; IN VITRO STUDY; IN VIVO STUDY; MICROCAPSULE; MICROENCAPSULATION; MOUSE; NONHUMAN;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIUM; CAPSULES; CATIONS; CELL DEATH; CELL LINE; CELL SHAPE; CELLS, IMMOBILIZED; CHITIN; DRUG COMPOUNDING; ERYTHROPOIETIN; HEMATOCRIT; MECHANICAL PHENOMENA; MICE; MICE, INBRED BALB C; MYOBLASTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 70450189312     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32270     Document Type: Article

References (38)

1. Chen H, Ouyang W, Jones M, Haque T, Lawuyi B, Prakash S. In-vitro analysis of APA microcapsules for oral delivery of live bacterial cells. J Microencapsul 2005;22:539-547. (Pubitemid 43123892)
2. Ouyang W, Chen H, Jones M, Metz T, Haque, Martoni C, Prakash S. Artificial cell microcapsule for oral delivery of live bacterial cells for therapy: Design, preparation, and in vitro characterization. J Pharm Pharm Sci 2004;7:315-324. (Pubitemid 41528880)
3. Orive G, Hernández RM, Gascón AR, Igartua M, Rojas A, Pedraz JL. Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells. Biotechnol Bioeng 2001;76:285-294. (Pubitemid 34015017)
4. Soon-Shiong P, Heintz R, Merideth N, Quiang X, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M. Insulin independence in a type I diabetic patient after encapsulated islet transplantation. Lancet 1994;343:950-951. (Pubitemid 24117231)
5. Schneider S, Feilen PJ, Brunnenmeier F, Minnemann T, Zimmermann H, Zimmermenn U, Weber MM. Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsulated after transplantation in immunocompetent diabetic mice. Diabetes 2005;54:687-693. (Pubitemid 40322070)
6. O'Loughlin JA, Bruder JM, Lysaght MJ. In vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganisms. Tissue Eng 2004;10:1446-1455.
7. Hortelano G, Al-Hendy A, Ofosu FA, Chang PL. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood 1996;87:5095-5103. (Pubitemid 26189850)
8. Rinsch C, Dupraz P, Schneider BL, Déglon N, Maxwell PH, Ratcliffe PJ, Aebischer P. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia. Kidney Int 2002;62:1395-1401.
9. Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Duna IF, Abe T, Carroll RS, Black PM. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001;19:35-39. (Pubitemid 32051953)
10. Kishima H, Poyot T, Bloch J, Dauguet J, Condé F, Dollé F, Hinnen F, Pralong W, Palfi S, Déglon N, Aebischer P, Hantraye P. Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: A pre-clinical study in chronicMPTP-treated baboons. Neurobiol Dis 2004;16:428-439. (Pubitemid 38757323)
11. Orive G, Hernández RM, Gascón AR, Calafiore R, Chang TMS, De Vos P, Hortelano G, Hunkeler D, Lacík I, Pedraz JL. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol 2004;22:87-92. (Pubitemid 38130176)
12. Lim F, Sum AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-909. (Pubitemid 11169847)
13. Strand BT, Ryan L, In't VP, Kulseng B, Rokstad AM, Skjåk-Bræk G, Espevik T. Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 2001;10:263-275.
14. Calafiore R, Basta G, Luca G, Boselli C, Bufalari A, Cassarani MP, Giustozzi GM, Brunetti P. Transplantation of pancreatic islets container in minimal volume microcapsules in diabetic high mammalians. Ann NY Acad Sci 1999;875:219-232. (Pubitemid 29349074)
15. Gåserød O, Smidsrød O, Skjåk-Bræk G. Microcapsules of alginate-chitosan.I. A quantitative study of the interaction between alginate and chitosan. Biomaterials 1998;19:1815-1825.
16. Gåserød O, Sannes A, Skjåk-Bræk G. Microcapsules of alginate-chitosan.II. A study of capsule stability and permeability. Biomaterials 1999;20:773-783.
17. Orive G, Bartkowiak A, Lisiecki S, De Castro M, Hernández RM, Gascón AR, Pedraz JL. Biocompatible oligochitosan as cationic modifiers of alginate/Ca microcapsules. J Biomed Mater Res B: Appl Biomater 2005;74:429-439. (Pubitemid 40917713)
18. Kas HS. Chitosans: Properties, preparation and application to microparticulate systems. J Microencapsul 1997;14:689-711. (Pubitemid 27483088)
19. Thu B, Bruheim P, Espevik T, Smidsrød O, Soon-Shiong P, Skjaëşk-Bræk G. Alginate polycationmicrocapsules-I. Interaction between alginate and polycation. Biomaterials 1996;17:1031-1040.
20. Bartkowiak A, Hunkeler D. New microcapsules based on oligoeletrolyte complexation. Ann NY Acad Sci 1999;875:36-46.
21. Kim JY, Lee JK, Lee TS, Park WH. Synthesis of chitooligosaccharide derivative with quaternary ammonium group and its antimicrobial activity against Streptococcus mutans. Int J Biol Macromol 2003;32:23-27.
22. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of the polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24:1121-1131.
23. Rehor A, Canaple C, Zhang Z, Hunkeler D. The compressive deformation of multicomponent microcapsules: Influence of size, membrane thickness, and compression speed. J Biomater Sci Polym Ed 2001;12:157-170. (Pubitemid 32515004)
24. Koepke JA. Microhematocrit method. In: Koepke JA, editor. Practical Laboratory Haematology. New York: Livingstone; 1991. p 112-114.
25. 2+/oligochitosan capsules. J Chem Technol Biotechnol 2006;81:511-518.
26. Orive G, De Castro M, Ponce S, Hernández RM, Gascón AR, Bosch M, Alberch J, Pedraz JL. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol Ther 2005;12:283-289. (Pubitemid 41025098)
27. Calafiore R, Basta G, Luca G, Calvitti M, Calíbrese G, Racanichi L, Macchiarulo G, Mancuso F, Guido L, Brunetti P. Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in non-immunosuppressed animals. Biotechnol Appl Biochem 2004;39:159-164. (Pubitemid 38510061)
28. Chang TMS. Artificial cells for cell and organ replacements. Artif Organs 2004;28:265-270.
29. Cirone P, Bourgeois JM, Shen F, Chan PL. Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells. Hum Gene Ther 2004;15:945-959. (Pubitemid 39372571)
30. Hortelano G, Xu N, Vandenberg A, Solera J, Chang PL, Ofosu FA. Persistent delivery of factor IX in mice: Gene therapy for hemophilia using implantable microcapsules. Hum Gene Ther 1999;10:1281-1288. (Pubitemid 29267583)
31. Baruch L, Machluf M. Alginate-chitosan complex coacervation for cell encapsulation: Effect on mechanical properties and on long-term viability. Biopolymers 2006;82:570-579. (Pubitemid 44204795)
32. Chen XG, Liu CS, Liu CG, Meng XH, Lee CM, Park HJ. Preparation and biocompatibility of chitosan microcarriers as biomaterial. Biochem Eng J 2005;27:269-274.
33. Vandevord PJ, Matthew HW, DeSilva SP, Mayton L, Wu B, Wooley PH. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002;59:585-590. (Pubitemid 34037503)
34. Yan XL, Khor E, Lim LY. Chitosan -alginate films prepared with chitosans of different molecular weights. J Biomed Mater Res 2001;58:358-365. (Pubitemid 32643183)
35. Bartkowiak A. Optimal conditions of transplantable binary polyelectrolyte microcapsules. Ann NY Acad Sci 2001;944:120-134. (Pubitemid 34053301)
36. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995;47:740-745.
37. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999;8:2627-2636. (Pubitemid 29181195)
38. Robitaille R, Dusseault J, Henley N, Desbiens K, Labrecque N, Hallé JP. Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules. Biomaterials 2005;26:4119-4127. (Pubitemid 40138658)